The mechanism of the pathogenesis of rheumatic fever and rheumatic carditis remains unknown (1). Efforts to vaccinate against group A streptococci have been hampered by toxicity of most preparations of M protein and the fear that streptococcal vaccines may contain some of the antigens shown to be cross-reactive with heart tissues (2-4) and, therefore, theoretically may trigger, rather than prevent, rheumatic fever and carditis.It has been recognized for a long time that the resistance of group A streptococci to phagocytosis is largely attributable to the presence on the surface of virulent organisms of a type-specific antigen, the M protein. Hosts who are immune to a particular M serotype of streptococci possess antibodies that render organisms bearing the homologous type of M protein on their surfaces susceptible to ingestion and killing by host phagocytes (5). Efforts to purify the M antigen in the past, however, have failed to separate heterologous protein antigens from the type-specific determinant of M protein (6-11). Moreover, after extensive purification, the M antigen often became less immunogenic and was of questionable value in affording protective immunity (12).In our search for more effective methods for the extraction and purification of M protein for use as vaccines, we found that the antigen could be extracted in satisfactory yields by subjecting intact streptococci to limited digestion with pepsin (13). Upon purification of the peptic extracts of types 6 and 24 M protein (pep M) 1 by ammoniumsulfate precipitation, ion-exchange chromatography, and isoelectric focusing, the heterologous, heart-reactive, and toxic materials were readily separated from the type-* Supported by program-directed research funds from the United States Veterans Administration and by research grants AI-10085 and AI-13550 from the United States Public Health Service.Presented in part at the annual meeting of the Association of American Physicians, Washington, D. C., May 1979.Medical Investigator of the Veterans Administration. § Research Associate of the Veterans Administration. i Abbreviations used in th,s paper." CF, complement fixation; CFU, colony-forming units; DCH, delayed cutaneous hypersensitivity; ELISA, enzyme-linked immunosorbent assay; NTSM, non-type-specific M; PBS, phosphate-buffered saline; PBS-Tween, PBS supplemented with 0.05% Tween and 0.02% NAN3; pep M, purified peptic extracts of types 6 and 24 M protein; pep M6, type 6 M protein pepsin extracts; pep M24, type 24 M protein pepsin extracts; saline, 0.85% solution of NaCI; saline-Tween, I ml of 0.15 M NaC1 containing 0.05% Tween; SDS, sodium dodecyl sulfate.
862J. ExP. MED.